Catalyst Event
Biogen Inc (BIIB) · Other
From Akros U.S. Tech 100 Protective Allocation Monthly Index (A100PAM)
3/20/2026, 12:00:00 AM
Biogen and partner Eisai to present new real-world data on their Alzheimer's drug LEQEMBI at the AD/PD 2026 conference on 2026-03-20; medium importance is estimated as real-world data for a key product typically influences market sentiment by ≥5%, scheduled.
Korean Translation
2026-03-20로 예정된 바이오짠과 팊트너사 에자이의 AD/PD 2026 컨퍼런스 내 알츠하이머 츘료제 레쯀비 실제 임상 데이터(real-world data) 발표이며, 주요 제품의 실제 데이터는 통상 5% 이상의 주가 변동을 야기하므로 중간 중요도로 예정됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
5/24/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Q4 and Full-Year Fiscal Year 2026 financial results scheduled; expected to have a medium impact as annual results typically influence guidance and investor sentiment.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM
GE Aerospace (GE) · Other
The 2026 Annual Shareholders Meeting to be held online on May 5, 2026, scheduled. Routine meetings typically result in minimal price movement.
5/5/2026, 12:00:00 AM